Plain-English translation of NCT02649985 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Sclerosis research guide →Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study uses a type of brain imaging called PET scanning to detect inflammation in the brain. Researchers want to understand how inflammation appears in people with multiple sclerosis and Alzheimer's disease, compared to people without these diseases. This could help doctors diagnose and understand these conditions better in the future.
Current brain imaging tools may not show inflammation clearly enough to help doctors diagnose or track these neurological diseases. This research aims to develop a better imaging method that can detect brain inflammation more reliably, which could change how doctors diagnose and treat these conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo brain imaging scans including PET and MRI imaging at Brigham and Women's Hospital. The researchers may test two slightly different imaging methods to see which works better. The entire imaging process typically takes a few hours, and you will be exposed to a small, safe amount of radiation. You may be asked to return for follow-up visits depending on the study phase you participate in.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
United States